{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2018"],"condition":["Colorectal Cancer","Colorectal Neoplasms"],"disease":["Colorectal Cancer","Colorectal Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2263115"],"location":["China"],"study_start_month":["1"],"keyword":["Apatinib"],"repository":["ECRIN MDR"],"study_status":["Not provided"],"additional_accession":[]},"is_claimable":false,"name":"Study of Apatinib Plus S-1 as the Therapy of Advanced Colorectal Cancer","description":"The purpose of this study is to confirm the safety and efficacy of Apatinib plus S-1 as the Therapy of Advanced Colorectal Cancer.","dates":{"creation":"2018-01-15"},"accession":"2263115","cross_references":{"ClinicalTrials___gov":["NCT03397199"]}}